Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.

Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.

Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427-kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the g...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Nowak, K, Davies, K
Format:	Journal article
Język:	English
Wydane:	2004

Podobne zapisy

Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
od: Yingyin Liang, i wsp.
Wydane: (2015-05-01)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2019)

Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
od: Davies, K, i wsp.
Wydane: (2019)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
od: Cedric Happi Mbakam, i wsp.
Wydane: (2022-03-01)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
od: Griffin, J, i wsp.
Wydane: (2002)

The Duchenne and Becker muscular dystrophy gene and protein product dystrophin
od: Monaco, A
Wydane: (1989)

Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy gene.
od: Monaco, A
Wydane: (1989)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
od: Frank, DE, i wsp.
Wydane: (2020)

Promising therapeutic approaches of utrophin replacing dystrophin in the treatment of Duchenne muscular dystrophy
od: Ruo Wu, i wsp.
Wydane: (2022-11-01)

Brain Dystrophin in Duchenne Dystrophy
od: J Gordon Millichap
Wydane: (1995-10-01)

Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
od: Krag, T, i wsp.
Wydane: (2001)

Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice
od: Yuan Zhou, i wsp.
Wydane: (2024-07-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
od: Elisabeth Le Rumeur
Wydane: (2015-07-01)

Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
od: Rasic Milic V., i wsp.
Wydane: (2014-12-01)

Duchenne muscular dystrophy treatment with lentiviral vector containing mini‐dystrophin gene in vivo
od: Xiaoyu Wang, i wsp.
Wydane: (2024-01-01)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
od: Perkins, K, i wsp.
Wydane: (2018)

Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.
od: Matthews, P, i wsp.
Wydane: (1995)

Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy
od: Amel Saoudi, i wsp.
Wydane: (2024-12-01)

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy
od: Mary Chesshyre, i wsp.
Wydane: (2022-04-01)

Carrier detection of duchenne and becker muscular dystrophy using muscle dystrophin immunohistochemistry
od: Acary S. Bulle Oliveira, i wsp.
Wydane: (1992-12-01)

Expression of dystrophin-glycoprotein complex at the skeletal muscle sarcolemma in Duchenne muscular dystrophy
od: Lei ZHAO, i wsp.
Wydane: (2015-06-01)

Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.
od: Peter J Taylor, i wsp.
Wydane: (2010-01-01)

Pharmacological advances for treatment in Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2017)

The Immune System in Duchenne Muscular Dystrophy Pathogenesis
od: Luana Tripodi, i wsp.
Wydane: (2021-10-01)

Regenerative biomarkers for Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2019)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
od: Betts, C, i wsp.
Wydane: (2014)

Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy.
od: Bauke Kogelman, i wsp.
Wydane: (2018-01-01)

Utrophin upregulation in Duchenne muscular dystrophy.
od: Hirst, R, i wsp.
Wydane: (2005)

Dystrophin and Diagnosis of Muscular Dystrophy
od: J Gordon Millichap
Wydane: (1990-10-01)

Progress in therapy for Duchenne muscular dystrophy.
od: Fairclough, R, i wsp.
Wydane: (2011)

Progress in therapy for Duchenne muscular dystrophy
od: Fairclough, R, i wsp.
Wydane: (2011)

Duchenne muscular dystrophy - past, present and future
od: Davies, K
Wydane: (2002)

Utrophin in the therapy of Duchenne Muscular Dystrophy
od: Potter, A, i wsp.
Wydane: (2006)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
od: van Westering, T
Wydane: (2018)

Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy
od: Liubov V. Gushchina, i wsp.
Wydane: (2022-12-01)

Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in Duchenne and Becker muscular dystrophy muscle biopsies
od: Janghra, N, i wsp.
Wydane: (2016)

Duchenne Muscular Dystrophy
od: J Gordon Millichap
Wydane: (1989-05-01)

Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model
od: Yosuke Hiramuki, i wsp.
Wydane: (2023-03-01)

Regenerative biomarkers for Duchenne muscular dystrophy
od: Simon Guiraud, i wsp.
Wydane: (2019-01-01)

Therapeutic approaches for Duchenne muscular dystrophy
od: Roberts, TC, i wsp.
Wydane: (2023)